Related Experiment Video
Updated: Sep 8, 2025

Near Infrared Photoimmunotherapy for Mouse Models of Pleural Dissemination
Published on: February 9, 2021
Clinical Experience of Using Remimazolam Instead of Volatile Anesthesia for Near-Infrared Photoimmunotherapy
Junya Matsumi1, Tetsufumi Sato1
1Department of Anesthesiology and Intensive Care Medicine, National Cancer Center Hospital, Tokyo, JPN.
Abstract:
Remimazolam is a newly-approved anesthetic agent, characterized by minimal hemodynamic fluctuations. We present a case of a patient who received three courses of near-infrared photoimmunotherapy for nasopharyngeal cancer. The patient had heart failure with reduced ejection fraction and aortic valve regurgitation. During the first two courses, the patient was anesthetized by sevoflurane with induction of midazolam and opioids and suffered hypotension requiring continuous infusion of noradrenaline. In the third course, the patient was anesthetized with remimazolam and opioids, and showed hemodynamic stability without the use of noradrenaline. This case report suggests the usefulness of remimazolam for hemodynamically vulnerable patients.
More Related Videos
Related Concept Videos
Parenteral Anesthetics: Overview
Inhalational Anesthetics: Overview
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
One of the advantages of...
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...

